Place in therapy of innovative drugs in multiple myeloma in 2021 and 2023 according to an expert panel Delphi consensus.

Mario B, Patrizia B, Sara B, Elena Z, Patrizia T, Nicola C, Nicola G, Donato M, Renato Z, Francesca P, Vittorio M, Mariella G, Francesco DR, Massimo O, Teresa PM, Pellegrino M.

Open source

DOI: 10.33393/grhta.2021.2245
Published: 2021-01-01
Container: Glob Reg Health Technol Assess
Publisher: Not recorded
Open access: yes

Credibility signals

uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
supportingDirectory of Open Access Journals: A matching record was returned by DOAJ. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.33393/grhta.2021.2245,
  title = {Place in therapy of innovative drugs in multiple myeloma in 2021 and 2023 according to an expert panel Delphi consensus.},
  author = {Mario B and  Patrizia B and  Sara B and  Elena Z and  Patrizia T and  Nicola C and  Nicola G and  Donato M and  Renato Z and  Francesca P and  Vittorio M and  Mariella G and  Francesco DR and  Massimo O and  Teresa PM and  Pellegrino M.},
  year = {2021},
  journal = {Glob Reg Health Technol Assess},
  doi = {10.33393/grhta.2021.2245},
  url = {https://doi.org/10.33393/grhta.2021.2245}
}

RIS

TY  - JOUR
TI  - Place in therapy of innovative drugs in multiple myeloma in 2021 and 2023 according to an expert panel Delphi consensus.
AU  - Mario B
AU  -  Patrizia B
AU  -  Sara B
AU  -  Elena Z
AU  -  Patrizia T
AU  -  Nicola C
AU  -  Nicola G
AU  -  Donato M
AU  -  Renato Z
AU  -  Francesca P
AU  -  Vittorio M
AU  -  Mariella G
AU  -  Francesco DR
AU  -  Massimo O
AU  -  Teresa PM
AU  -  Pellegrino M.
PY  - 2021
JO  - Glob Reg Health Technol Assess
DO  - 10.33393/grhta.2021.2245
UR  - https://doi.org/10.33393/grhta.2021.2245
ER  -

APA

B, M., B, P., B, S., Z, E., T, P., C, N., G, N., M, D., Z, R., P, F., M, V., G, M., DR, F., O, M., PM, T., & M., P. (2021). Place in therapy of innovative drugs in multiple myeloma in 2021 and 2023 according to an expert panel Delphi consensus.. Glob Reg Health Technol Assess. https://doi.org/10.33393/grhta.2021.2245

Source records

europe-pmc · retrieved 2026-09-27T16:23:47.213Z
doaj · retrieved 2026-09-27T16:23:47.148Z